ALGS · Aligos Therapeutics, Inc.
$4.33
+0.08 (+1.88%)
At close · Jul 30
Going-concern doubt
— flagged May 7, 2026
Substantial doubt about the company's ability to continue as a going concern.
“our recurring losses from operations and negative cash flows have raised substantial doubt regarding our ability to continue as a going concern”View the 10-Q filed May 7, 2026
Market Cap
$15.25M
Shares
3.59M
Fails to deliver — shares from a trade that were not delivered to the buyer by the settlement date — published by the SEC twice a month. Persistent fails can reflect settlement problems or naked short selling.
Fails to Deliver History
| Settlement Date | Quantity | Price | Value |
|---|---|---|---|
| 2026-07-14 | 7,076 | $6.36 | $45,003 |
| 2026-07-13 | 2,709 | $6.62 | $17,934 |
| 2026-07-10 | 504 | $6.77 | $3,412 |
| 2026-07-09 | 25 | $6.73 | $168 |
| 2026-07-08 | 1,574 | $6.09 | $9,586 |
| 2026-07-07 | 1,568 | $5.85 | $9,173 |
| 2026-06-30 | 281 | $5.43 | $1,526 |
| 2026-06-26 | 1 | $5.50 | $6 |
| 2026-06-24 | 751 | $5.65 | $4,243 |
| 2026-06-17 | 406 | $4.99 | $2,026 |
| 2026-06-16 | 806 | $5.11 | $4,119 |
| 2026-06-09 | 1,458 | $4.96 | $7,232 |
| 2026-06-08 | 10,629 | $4.91 | $52,188 |
| 2026-06-04 | 1,109 | $5.14 | $5,700 |
| 2026-06-03 | 490 | $5.25 | $2,573 |
| 2026-06-01 | 10,505 | $5.70 | $59,879 |
| 2026-05-19 | 100 | $5.36 | $536 |
| 2026-05-18 | 327 | $5.71 | $1,867 |
| 2026-05-13 | 7,723 | $6.47 | $49,968 |
| 2026-05-12 | 3,633 | $6.21 | $22,561 |
| 2026-05-11 | 1,986 | $6.44 | $12,790 |
| 2026-05-07 | 4,664 | $6.37 | $29,710 |
| 2026-05-06 | 1,525 | $6.35 | $9,684 |
| 2026-05-05 | 1,723 | $6.44 | $11,096 |
| 2026-05-04 | 1,788 | $6.09 | $10,889 |
| 2026-04-30 | 1,649 | $5.97 | $9,845 |
Showing 1–26 of 26 settlements